72 participants
Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2015-06-30
- Start Date:
- 2009-01-31
- Completion:
- 2014-12-31
Conditions
- Amyloidosis
Interventions
- DRUG
No Results Yet